Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
COMPLETED
NCT03996772
PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation
319
Enrollment(s)
64
Study location(s)
INTERVENTIONAL (PHASE3)
Atrial Fibrillation
Intracerebral Hemorrhage
ACTIVE_NOT_RECRUITING
NCT03950076
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
948
Enrollment(s)
152
Study location(s)
INTERVENTIONAL (PHASE4)
Intracranial Hemorrhages
Atrial Fibrillation
COMPLETED
NCT03523572
Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer
86
Enrollment(s)
29
Study location(s)
INTERVENTIONAL (PHASE1)
Breast Cancer
Urothelial Carcinoma
RECRUITING
NCT03127631
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
6,000
Enrollment(s)
54
Study location(s)
INTERVENTIONAL (NA)
Prostate Cancer
Cardiovascular Disease
COMPLETED
NCT02834390
Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
7
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1)
Acute Myeloid Leukemia
COMPLETED
NCT02798471
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
290
Enrollment(s)
140
Study location(s)
INTERVENTIONAL (PHASE3)
Venous Thromboembolism (VTE)
Pulmonary Embolism
Deep Vein Thrombosis (DVT)
TERMINATED
NCT02618577
Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
2,608
Enrollment(s)
18
Study location(s)
INTERVENTIONAL (PHASE3)
Atrial High Rate Episodes
COMPLETED
NCT02401815
CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors
51
Enrollment(s)
6
Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Gastrointestinal Stromal Tumors
26
27
28
29
30